Application Information

This drug has been submitted to the FDA under the reference 021549/001.

Names and composition

"EMEND" is the commercial name of a drug composed of APREPITANT.
It belongs to the class Neurokinin NK 1 antagonists and is used in Nausea, vomiting (Central Nervous System)

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
021549/001 EMEND APREPITANT CAPSULE/ORAL 80MG
021549/002 EMEND APREPITANT CAPSULE/ORAL 125MG
021549/003 EMEND APREPITANT CAPSULE/ORAL 40MG
022023/001 EMEND FOSAPREPITANT DIMEGLUMINE POWDER/INTRAVENOUS EQ 115MG BASE per VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
022023/002 EMEND FOSAPREPITANT DIMEGLUMINE POWDER/INTRAVENOUS EQ 150MG BASE per VIAL
207865/001 EMEND APREPITANT FOR SUSPENSION/ORAL 125MG per KIT

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
021549/001 EMEND APREPITANT CAPSULE/ORAL 80MG
021549/002 EMEND APREPITANT CAPSULE/ORAL 125MG
021549/003 EMEND APREPITANT CAPSULE/ORAL 40MG
090999/001 APREPITANT APREPITANT CAPSULE/ORAL 40MG
090999/002 APREPITANT APREPITANT CAPSULE/ORAL 80MG
090999/003 APREPITANT APREPITANT CAPSULE/ORAL 125MG
207865/001 EMEND APREPITANT FOR SUSPENSION/ORAL 125MG per KIT

Manufacturers

Manufacturer name
Merck Sharp & Dohme Ltd

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved